Author: Brian Mattmiller

Morgridge, campus partner to power up ‘mass spec’ potential

The Morgridge Institute for Research, as part of its Metabolism Initiative, is working with a University of Wisconsin–Madison team to greatly expand the scope of “mass spec” applications on campus. A new resource housed in the UW–Madison Biotechnology Center brings together a multi-million dollar investment in mass spectrometry tools from multiple sources to form a central repository to tackle large-scale investigations.

Scheufele named to gene editing panel

Dietram Scheufele, professor of life sciences communication at UW–Madison and Morgridge Institute for Research affiliate, will serve on a national panel examining the implications of human genome editing.

New stem cell process increases therapeutic potential

Researchers from the Morgridge Institute for Research and the Murdoch Children’s Research Institute (MCRI) in Australia have devised a way to dramatically cut the time involved in reprogramming and genetically correcting stem cells, an important step to making future therapies possible.

High-throughput computing, HIV and the mystery of ‘elite controllers’

In August 2015, just before going on vacation, virology researcher Dave O’Connor teed up the largest data analysis challenge of his lifetime. The computing run included 694 independent jobs, each one with about one billion points of genomic data to process. O’Connor returned to find that his “set it and forget it” gamble paid off handsomely: 693 of the 694 computing runs had fully completed, with zero human intervention.

Stem cells help predict neural toxicity

A new system developed by scientists at the Morgridge Institute for Research and the University of Wisconsin–Madison may provide a faster, cheaper and more biologically relevant way to screen drugs and chemicals that could harm the developing brain.